Free Trial

YS Biopharma (YS) Institutional Ownership

→ Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad)
Free YS Stock Alerts
$0.75
-0.05 (-6.25%)
(As of 03:25 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for YS Biopharma (NASDAQ:YS)

Current
Institutional Ownership
Percentage
52.64%
Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$11.92M
Number of
Institutional Sellers
(last 12 months)
0
Get YS Insider Trade Alerts

Want to know when executives and insiders are buying or selling YS Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

YS Institutional Buying and Selling by Quarter

YS Biopharma Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/14/2024Superstring Capital Management LP307,920$166K0.1%N/A0.331%
9/21/2023Barclays PLC108,894$150K0.0%N/A0.423%
8/14/2023Prelude Capital Management LLC32,200$44K0.0%N/A0.125%
5/16/2023Snow Lake Management LP1,811,942$2.90M1.7%N/A7.037%
5/16/2023Hhlr Advisors LTD.751,790$1.20M0.0%N/A2.920%
5/15/2023RTW Investments LP341,090$546K0.0%N/A1.325%
5/11/2023FIL Ltd2,718,499$4.35M0.0%N/A10.557%
5/10/2023Valliance Asset Management Ltd1,607,175$2.57M4.6%N/A6.241%
(Data available from 1/1/2016 forward)

YS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of YS shares?

During the previous two years, the following institutional investors and hedge funds held shares of YS Biopharma shares: FIL Ltd ($4.35M), Snow Lake Management LP ($2.90M), Valliance Asset Management Ltd ($2.57M), Hhlr Advisors LTD. ($1.20M), RTW Investments LP ($546K), Superstring Capital Management LP ($166K), and Barclays PLC ($150K).Learn more on YS's institutional investors.

What percentage of YS Biopharma stock is owned by institutional investors?

52.64% of YS Biopharma stock is owned by institutional investors. Learn more on YS's institutional investor holdings.

Which institutional investors have been buying YS Biopharma stock?

The following institutional investors have purchased YS Biopharma stock in the last 24 months: FIL Ltd ($2.72M), Snow Lake Management LP ($1.81M), Valliance Asset Management Ltd ($1.61M), Hhlr Advisors LTD. ($751.79K), RTW Investments LP ($341.09K), Superstring Capital Management LP ($307.92K), and Barclays PLC ($108.89K).

How much institutional buying is happening at YS Biopharma?

Institutional investors have bought a total of 7,679,510 shares in the last 24 months. This purchase volume represents approximately $11.92M in transactions.


Related Companies:
This page (NASDAQ:YS) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The #1 Biotech Stock to Have on Your Radar in 2024…
Huge Alerts
AI finds its first serious application
Wall Street Star
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
He Is Giving Away Bitcoin
Crypto Swap Profits
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
4 coins to be the “Next Bitcoin”
True Market Insiders